If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Declaration

15 Jun 2021 07:40

RNS Number : 9206B
Balfour Beatty PLC
15 June 2021
 

 

 

DIRECTOR DECLARATION

15 June 2021

In accordance with Listing Rule 9.6.14R (2), Balfour Beatty plc ("Balfour Beatty"), the international infrastructure group, announces that Barbara Moorhouse, Independent Non-Executive Director of Balfour Beatty, will be appointed as the Senior Independent Non-Executive Director and Chair of the Audit Committee of Medica Group Plc with effect from 1 July 2021.

 

 

Analyst/investor enquiries:

Angus BarryTel. +44 (0)7966 281 635angus.barry@balfourbeatty.com

 

Media enquiries: 

Antonia WaltonTel. +44 (0) 7966 929 633antonia.walton@balfourbeatty.com

 

Notes to editors:

· Balfour Beatty is a leading international infrastructure group with 26,000 employees driving the delivery of powerful new solutions, shaping thinking, creating skylines and inspiring a new generation of talent to be the change-makers of tomorrow.

· We finance, develop, build, maintain and operate the increasingly complex and critical infrastructure that supports national economies and deliver projects at the heart of local communities.

· Over the last 112 years we have created iconic buildings and infrastructure all over the world including: the £1.5 billion A14 improvement scheme - Britain's biggest road project; Hong Kong's HK$5.5 billion world-class harbour theatre project for the West Kowloon Cultural District Authority; and the 12.5 mile $429 million North Metro Commuter Rail line in Colorado, US.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNGPUBWQUPGUQA
Date   Source Headline
6th Jul 20233:29 pmRNSForm 8.3 - Medica Group plc
6th Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
6th Jul 20233:00 pmRNSForm 8.3 - Medica Group PLC
6th Jul 20231:28 pmRNSHolding(s) in Company
6th Jul 202310:26 amGNWRule 8.3 - Medica Group Plc
6th Jul 202310:01 amRNSScheme of Arrangement becomes Effective
6th Jul 20239:32 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
6th Jul 20239:18 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
5th Jul 20233:39 pmRNSDirector/PDMR Shareholding
5th Jul 20233:29 pmRNSForm 8.3 - Medica Group plc
5th Jul 202310:32 amGNWRule 8.3 - Medica Group Plc
5th Jul 20239:13 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
5th Jul 20238:49 amRNSForm 8.5 (EPT/RI)
5th Jul 20237:52 amRNSForm 8.3 - Medica Group PLC
4th Jul 20233:30 pmRNSForm 8.3 - MGP LN
4th Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
4th Jul 20233:00 pmRNSForm 8.3 - Medica Group PLC
4th Jul 20232:57 pmRNSForm 8.3 - MEDICA GROUP PLC
4th Jul 20232:53 pmPRNForm 8.3 - Medica Group Plc
4th Jul 202312:37 pmRNSIssue of Equity and Rule 2.9 Announcement
4th Jul 202312:18 pmRNSCourt Sanction of Scheme of Arrangement
4th Jul 202312:17 pmRNSForm 8.3 - Medica Group PLC
4th Jul 202310:58 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
4th Jul 20239:47 amRNSForm 8.5 (EPT/RI) - Medica Group Plc
4th Jul 20239:11 amRNSForm 8.5 (EPT/RI)
3rd Jul 20233:30 pmRNSForm 8.3 - MGP LN
3rd Jul 20233:25 pmBUSForm 8.3 - Medica Group plc
3rd Jul 20233:01 pmPRNForm 8.3 - Medica Group Plc
3rd Jul 20232:39 pmPRNForm 8.3 - Medica Group Plc
3rd Jul 202311:04 amRNSForm 8.3 - Medica Group PLC
3rd Jul 20239:32 amRNSHolding(s) in Company
3rd Jul 20239:16 amRNSForm 8.5 (EPT/RI)
3rd Jul 20237:00 amRNSForm 8.3 - Medica Group PLC
30th Jun 20233:25 pmBUSForm 8.3 - Medica Group plc
30th Jun 20233:08 pmRNSForm 8.3 - Medica Group PLC
30th Jun 20232:38 pmPRNForm 8.3 - Medica Group Plc
30th Jun 202312:59 pmPRNForm 8.3 - Medica Group Plc
30th Jun 202311:53 amRNSResult of Annual General Meeting
30th Jun 20237:00 amRNSAGM Statement
29th Jun 20235:30 pmRNSMedica Group
29th Jun 20233:25 pmBUSForm 8.3 - Medica Group plc
29th Jun 20233:21 pmRNSHolding(s) in Company
29th Jun 20233:10 pmRNSForm 8.3 - Medica Group PLC
29th Jun 20232:47 pmPRNForm 8.3 - Medica Group Plc
29th Jun 20239:46 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
29th Jun 20239:10 amRNSForm 8.5 (EPT/RI)
28th Jun 20233:42 pmBUSForm 8.3 - Medica Group plc
28th Jun 20233:03 pmRNSForm 8.3 - MEDICA GROUP PLC
28th Jun 20231:30 pmPRNForm 8.3 - Medica Group Plc
28th Jun 202311:16 amRNSForm 8.3 - Medica Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.